Search - tctmd.com

Displaying 581 - 600 of 806

Sort: Relevancy | Date

Presentation ACC 2014

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 31, 2014

Presentation CIT 2014

Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stents at 3 months follow-up: The BuMA-OCT Randomized Trial

Presenter: Yao-Jun Zhang

March 22, 2014

Presentation CTO 2014

Left Main Restenosis: Incidence, Implications, and Management

Presenter: Roxana Mehran

March 01, 2014

Presentation CTO 2014

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Presenter: Martin B. Leon

March 01, 2014

Presentation CTO 2014

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Presenter: Antonio Colombo

March 01, 2014

Presentation CTO 2014

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Presenter: Philippe Généreux

March 01, 2014

Presentation ISET 2014

Thrombus Laden Occlusions: Covered Stents vs. Lysis

Presenter: Richard R. Saxon

January 21, 2014

Presentation ISET 2014

Next Generation Stents: How Will They Be Used?

Presenter: Mahmood Razavi

January 21, 2014

Presentation

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

Presenter: Fabrizio Tomai

January 07, 2014

Presentation

Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly

Presenter: T.W. Yeh

December 12, 2013

Presentation TCT 2013

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Presenter: Gilles Montalescot

October 31, 2013

Presentation TCT 2013

Mesh-Covered Stents Are Optimal Management Strategy for Thrombus!

Presenter: Dariusz Dudek

October 31, 2013

Presentation TCT 2013

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Presenter: George Dangas

October 31, 2013

Presentation TCT 2013

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Presenter: Praveen Chandra

October 31, 2013

Presentation TCT 2013

Indigenous Stents: New Technologies and Clinical Data

Presenter: Sreenivas Kumar

October 31, 2013

Presentation TCT 2013

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Presenter: Clemens von Birgelen

October 31, 2013

Presentation TCT 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presenter: J?rg Schr?der

October 31, 2013

Presentation TCT 2013

Case 4 : A Complex Bifurcation with Planned 2 Stents

Presenter: Alaide Chieffo

October 30, 2013

Presentation TCT 2013

Case #1: One or Two Stents? Long-term Results from Nordic Baltic I Changed My Strategy!

Presenter: Michael Maeng

October 30, 2013

Presentation TCT 2013

Case #11: In the Future Bifurcation Stents Will Disappear!

Presenter: Evald Christiansen

October 30, 2013

Advertisement

Two-Year Outcome of a Randomized Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Optical coherence tomography assessment of a PLGA-polymer with electro-grafting base layer versus a PLA-polymer sirolimus-eluting stents at 3 months follow-up: The BuMA-OCT Randomized Trial

Left Main Restenosis: Incidence, Implications, and Management

Dedicated Bifurcation Stents in Left Main Disease: Do the Data Support Their Need?

Bioresorbable Scaffolds in Left Main PCI: Technique Considerations and Outcomes

Are There Meaningful Differences Between Metallic DES in Left Main PCI?

Thrombus Laden Occlusions: Covered Stents vs. Lysis

Next Generation Stents: How Will They Be Used?

Randomized Comparison of Xience V and Multi-link Stents in the Same Multivessel Patient with CKD

Instrumental Variable Analysis to Compare Effectiveness of Stents in the Extremely Elderly

Self-Expanding Stents Provide a Real Benefit During STEMI Intervention!

Mesh-Covered Stents Are Optimal Management Strategy for Thrombus!

FREEDOM: A Prospective, Randomized Trial of First Generation Drug-Eluting Stents vs. CABG in Insulin- and Noninsulin-Treated Diabetic Patients

Update on Device Therapy for STEMI: Stents and Thrombectomy/Embolic Protection

Indigenous Stents: New Technologies and Clinical Data

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Case 4 : A Complex Bifurcation with Planned 2 Stents

Case #1: One or Two Stents? Long-term Results from Nordic Baltic I Changed My Strategy!

Case #11: In the Future Bifurcation Stents Will Disappear!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content